Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 5
2011 5
2012 13
2013 10
2014 11
2015 16
2016 18
2017 14
2018 21
2019 16
2020 13
2021 14
2022 14
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
New Therapies for Advanced Thyroid Cancer.
Laha D, Nilubol N, Boufraqech M. Laha D, et al. Among authors: nilubol n. Front Endocrinol (Lausanne). 2020 May 22;11:82. doi: 10.3389/fendo.2020.00082. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32528402 Free PMC article. Review.
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Among authors: nilubol n. Lancet Diabetes Endocrinol. 2023 May;11(5):345-361. doi: 10.1016/S2213-8587(23)00038-4. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011647 Review.
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.
Roper N, Brown AL, Wei JS, Pack S, Trindade C, Kim C, Restifo O, Gao S, Sindiri S, Mehrabadi F, El Meskini R, Ohler ZW, Maity TK, Venugopalan A, Cultraro CM, Akoth E, Padiernos E, Chen H, Kesarwala A, Smart DK, Nilubol N, Rajan A, Piotrowska Z, Xi L, Raffeld M, Panchenko AR, Sahinalp C, Hewitt S, Hoang CD, Khan J, Guha U. Roper N, et al. Among authors: nilubol n. Cell Rep Med. 2020 Apr 21;1(1):100007. doi: 10.1016/j.xcrm.2020.100007. Cell Rep Med. 2020. PMID: 32483558 Free PMC article. Clinical Trial.
Preclinical Models of Adrenocortical Cancer.
Sedlack AJH, Hatfield SJ, Kumar S, Arakawa Y, Roper N, Sun NY, Nilubol N, Kiseljak-Vassiliades K, Hoang CD, Bergsland EK, Hernandez JM, Pommier Y, Del Rivero J. Sedlack AJH, et al. Among authors: nilubol n. Cancers (Basel). 2023 May 23;15(11):2873. doi: 10.3390/cancers15112873. Cancers (Basel). 2023. PMID: 37296836 Free PMC article. Review.
Precision Surgery for Pheochromocytomas and Paragangliomas.
Wiseman D, Lakis ME, Nilubol N. Wiseman D, et al. Among authors: nilubol n. Horm Metab Res. 2019 Jul;51(7):470-482. doi: 10.1055/a-0926-3618. Epub 2019 Jul 15. Horm Metab Res. 2019. PMID: 31307109 Free PMC article. Review.
Current Status and Future Targeted Therapy in Adrenocortical Cancer.
Alyateem G, Nilubol N. Alyateem G, et al. Among authors: nilubol n. Front Endocrinol (Lausanne). 2021 Mar 1;12:613248. doi: 10.3389/fendo.2021.613248. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33732213 Free PMC article. Review.
155 results